Copyright
©The Author(s) 2025.
World J Diabetes. Jul 15, 2025; 16(7): 106903
Published online Jul 15, 2025. doi: 10.4239/wjd.v16.i7.106903
Published online Jul 15, 2025. doi: 10.4239/wjd.v16.i7.106903
Table 1 Distribution of pathogens
Pathogenic bacteria | Number | Composition ratio (%) |
Gram positive bacteria | 19 | 35.85 |
Staphylococcus aureus | 10 | 18.87 |
Streptococcus pneumoniae | 2 | 3.77 |
Staphylococcus epidermidis | 7 | 13.21 |
Gram negative bacteria | 34 | 64.15 |
Acinetobacter baumannii | 5 | 9.43 |
Pseudomonas aeruginosa | 14 | 26.42 |
Klebsiella pneumoniae | 8 | 15.09 |
Escherichia coli | 4 | 7.55 |
Tenotrophomonas maltophilia | 3 | 5.66 |
Table 2 Comparison of general data, mean ± SD/n (%)
Items | Infected group (n = 41) | Non-infected group (n = 171) | t/χ2 value | P value | |
Age (years old) | ≥ 70 | 27 (65.85) | 76 (44.44) | 4.767 | 0.029 |
60-69 | 14 (34.15) | 95 (55.55) | |||
Sex (cases) | Male | 24 (58.54) | 112 (65.50) | 0.697 | 0.404 |
Female | 17 (41.46) | 59 (34.50) | |||
Body mass index (kg/m2) | 25.42 ± 2.13 | 24.79 ± 2.09 | 1.547 | 0.123 | |
Smoking history | With | 23 (56.10) | 101 (59.06) | 0.120 | 0.729 |
Without | 18 (43.90) | 70 (40.94) | |||
Drinking history | With | 22 (53.66) | 79 (46.20) | 0.738 | 0.390 |
Without | 19 (46.34) | 92 (53.80) | |||
Hypertension | With | 27 (65.85) | 94 (54.97) | 1.599 | 0.206 |
Without | 14 (34.15) | 77 (45.03) | |||
Hyperlipidemia | With | 14 (34.15) | 82 (47.95) | 2.544 | 0.111 |
Without | 27 (65.85) | 89 (52.05) | |||
Respiratory diseases | With | 25 (60.98) | 71 (41.52) | 5.052 | 0.026 |
Without | 16 (39.02) | 100 (58.48) | |||
TNM stage | I stage | 16 (39.02) | 98 (57.31) | 4.448 | 0.035 |
II-III stage | 25 (60.98) | 73 (42.69) | |||
Maximum diameter of tumor | ≥ 4 cm | 22 (53.66) | 60 (35.09) | 4.809 | 0.028 |
< 4 cm | 19 (46.34) | 111 (64.91) | |||
Neoadjuvant chemotherapy | ≥ 2 times | 27 (65.85) | 64 (37.43) | 10.908 | < 0.001 |
< 2 times | 14 (34.15) | 107 (62.57) | |||
Pathological type | Squamous carcinoma | 22 (53.66) | 111 (64.91) | 1.792 | 0.181 |
Adenocarcinoma | 19 (46.34) | 60 (35.09) |
Table 3 Comparison of surgical treatment and laboratory indicators, mean ± SD/n (%)
Items | Infected group (n = 41) | Non-infected group (n = 171) | t/χ2 value | P value | |
Operation time (hour) | ≥ 3 | 25 (60.98) | 72 (42.11) | 4.745 | 0.029 |
< 3 | 16 (39.02) | 99 (57.89) | |||
Intraoperative bleeding (mL) | ≥ 800 | 11 (26.83) | 38 (22.22) | 0.395 | 0.530 |
< 800 | 30 (73.17) | 133 (77.77) | |||
Extent of excision | Multi leaf | 28 (68.29) | 75 (43.86) | 7.903 | 0.005 |
Single leaf | 13 (31.71) | 96 (56.14) | |||
Thoracic drainage tube time (day) | ≥ 3.5 | 26 (63.41) | 61 (35.67) | 10.519 | < 0.001 |
< 3.5 | 15 (36.59) | 110 (64.33) | |||
Forced expiratory volume in one second (%) | < 80 | 28 (68.28) | 68 (39.77) | 10.861 | < 0.001 |
≥ 80 | 13 (31.71) | 103 (60.23) | |||
White blood cell count (× 109/L) | 8.42 ± 1.39 | 8.79 ± 1.15 | -1.774 | 0.078 | |
C-reactive protein (mg/L) | 3.42 ± 1.51 | 3.73 ± 1.45 | -1.220 | 0.224 | |
Albumin (g/L) | 39.74 ± 1.72 | 41.87 ± 1.62 | -7.471 | < 0.001 | |
Fasting blood glucose (mmol/L) | 7.02 ± 1.25 | 6.48 ± 1.21 | 2.55 | 0.011 | |
Hemoglobin A1c (%) | 8.12 ± 1.04 | 7.12 ± 1.01 | 5.661 | < 0.001 |
Table 4 Risk factors and their assignment for pulmonary infection in patients
Factor | Variable | Assignment |
Age | X1 | 60-69 years old, 0; ≥ 70 years old, 1 |
TNM stage | X2 | I stage, 0; II-III stage, 1 |
Respiratory diseases | X3 | No, 0; Yes, 1 |
Neoadjuvant chemotherapy | X4 | < 2 times, 0; ≥ 2 times, 1 |
Maximum diameter of tumor | X5 | < 4 cm, 0; ≥ 4 cm, 1 |
Operation time | X6 | < 3 hours, 0; ≥ 3 hours, 1 |
Range of excision | X7 | Single leaf, 0; multi leaf, 1 |
Thoracic drainage tube time | X8 | < 3.5 days, 0; ≥ 3.5 days, 1 |
Forced expiratory volume in one second | X9 | ≤ 80%, 0; > 80%, 1 |
Albumin | X10 | Actual measurement value |
Fasting blood glucose | X11 | Actual measurement value |
Hemoglobin A1c | X12 | Actual measurement value |
Table 5 Multivariate risk analysis for postoperative pulmonary infection in elderly diabetic lung cancer patients
Factor | P value | OR | 95%CI |
Age | 0.063 | 2.735 | 0.948-7.89 |
TNM stage | 0.084 | 2.486 | 0.886-6.973 |
Respiratory diseases | 0.849 | 1.105 | 0.397-3.071 |
Neoadjuvant chemotherapy | 0.036 | 2.987 | 1.072-8.318 |
Maximum diameter of tumor | 0.013 | 3.959 | 1.341-11.69 |
Operation time | 0.079 | 2.518 | 0.899-7.051 |
Range of excision | 0.036 | 3.18 | 1.08-9.361 |
Thoracic drainage tube time | 0.224 | 1.878 | 0.68-5.186 |
Forced expiratory volume in one second | 0.029 | 3.305 | 1.129-9.673 |
Albumin | 0.000 | 0.507 | 0.362-0.709 |
Fasting blood glucose | 0.562 | 1.132 | 0.745-1.719 |
Hemoglobin A1c | 0.003 | 2.39 | 1.346-4.241 |
Table 6 Area under the curve for predicting postoperative pulmonary infection in elderly diabetic lung cancer patients
Factor | AUC | SE | 95%CI |
Neoadjuvant chemotherapy | 0.642 | 0.048 | 0.548-0.736 |
Maximum diameter of tumor | 0.593 | 0.05 | 0.495-0.691 |
Range of excision | 0.622 | 0.048 | 0.528-0.716 |
Forced expiratory volume in one second | 0.667 | 0.046 | 0.577-0.757 |
Albumin | 0.795 | 0.039 | 0.718-0.871 |
Hemoglobin A1c | 0.744 | 0.044 | 0.659-0.829 |
- Citation: Chen ZY, Hong ZQ, Wang TQ, Fu GMZ, Su WM, Zhou CW. Risk factors for pulmonary infection after thoracoscopic radical resection of lung cancer in elderly patients with diabetes mellitus. World J Diabetes 2025; 16(7): 106903
- URL: https://www.wjgnet.com/1948-9358/full/v16/i7/106903.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i7.106903